| Heptamethine cyanine dye mediated drug delivery: hype or hope PJ Choi, TIH Park, E Cooper, M Dragunow, WA Denny, J Jose Bioconjugate Chemistry 31 (7), 1724-1739, 2020 | 43 | 2020 |
| The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell … PJ Choi, E Cooper, P Schweder, E Mee, R Faull, WA Denny, M Dragunow, ... Bioorganic & medicinal chemistry letters 29 (18), 2617-2621, 2019 | 23 | 2019 |
| The use of heptamethine cyanine dyes as drug-conjugate systems in the treatment of primary and metastatic brain tumors E Cooper, PJ Choi, WA Denny, J Jose, M Dragunow, TIH Park Frontiers in oncology 11, 654921, 2021 | 21 | 2021 |
| PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines PJ Choi, E Cooper, P Schweder, E Mee, C Turner, R Faull, WA Denny, ... Bioorganic & Medicinal Chemistry Letters 30 (14), 127252, 2020 | 14 | 2020 |
| Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines E Cooper, PJ Choi, P Schweder, E Mee, C Turner, R Faull, WA Denny, ... Bioorganic & Medicinal Chemistry Letters 50, 128336, 2021 | 7 | 2021 |
| Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action PJ Choi, P Tomek, M Tercel, J Reynisson, TIH Park, EA Cooper, ... Molecules 27 (3), 880, 2022 | 6 | 2022 |
| Single-cell image analysis reveals overexpression of organic-anion transporting polypeptides (OATPs) in human glioblastoma tissue E Cooper, Z Woolf, M E.V Swanson, J Correia, P Schweder, E Mee, ... Neurooncology Advances, 2022 | 5 | 2022 |
| Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug‐carrier molecule for the treatment of glioblastoma E Cooper, PJ Choi, K Hwang, KM Nam, CY Kim, T Shaban, P Schweder, ... Chemical biology & drug design 101 (3), 696-716, 2023 | 3 | 2023 |
| Novel synthetic approach for accessing drug–dye conjugates for targeted tumour therapy PJ Choi, EA Cooper, TIH Park, WA Denny, J Jose Results in Chemistry 4, 100343, 2022 | 2 | 2022 |
| The synthesis of drug-dye conjugates using pre-established tyrosine kinase inhibitors and tumour-selective Heptamethine Cyanine Dyes for the treatment of glioblastoma A Cullen, E Cooper, WA Denny, M Dragunow, PJ Choi, TIH Park, J Jose Brain Tumor Research and Treatment 10 (Suppl), 2022 | 1 | 2022 |
| Improving the Therapeutic Potential of Tyrosine Kinase Inhibitors in the Treatment of Glioblastoma: Conjugation with Heptamethine Cyanine Dyes EA Cooper PhD Thesis-University of Auckland, 2023 | | 2023 |
| The development of a potent, tumour-specific heptamethine cyanine dye-palbociclib conjugate with novel mechanisms of action for the treatment of glioblastoma EA Cooper, PJ Choi, P Schweder, J Correia, C Turner, R Faull, WA Denny, ... NEURO-ONCOLOGY 24, 2022 | | 2022 |
| Multidimensional neuronal mechanisms drive glioblastoma cell invasion V Venkataramani, Y Yang, M Schubert, S Tetzlaff, M Botz, C Beretta, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| The development of a potent, tumour-specific heptamethine cyanine dye-crizotinib conjugate for the treatment of glioblastoma EA Cooper, PJ Choi, KM Nam, P Schweder, E Mee, C Turner, R Faull, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| Conjugation of palbociclib with MHI-148 has an increased cytotoxic effect for breast cancer cells and an altered mechanism of action E Leung, P Tomek, M Tercel, J Reynisson, T Park, E Cooper, W Denny, ... bioRxiv, 2021.11. 02.466693, 2021 | | 2021 |
| CCDC 2105642: Experimental Crystal Structure Determination A Cullen, J Jose, E Cooper, I Park, K Noguchi, P Choi | | 2021 |
